• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Advanced Pharmacy Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 9 (2025)
Issue Issue 2
Issue Issue 1
Volume Volume 8 (2024)
Volume Volume 7 (2023)
Volume Volume 6 (2022)
Volume Volume 5 (2021)
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Naqvi, M., Al-Sulivany, B., Naeem, M., Selamoglu, Z., Issa alhussein, H. (2025). Myricetin: Unleashing Nature’s Anticancer Warrior for A Healthier Tomorrow. Journal of Advanced Pharmacy Research, 9(1), 1-10. doi: 10.21608/aprh.2025.308641.1285
Muhammad Naqvi; Basim Al-Sulivany; Muhammad Naeem; Zeliha Selamoglu; Hamdia Yousif Issa alhussein. "Myricetin: Unleashing Nature’s Anticancer Warrior for A Healthier Tomorrow". Journal of Advanced Pharmacy Research, 9, 1, 2025, 1-10. doi: 10.21608/aprh.2025.308641.1285
Naqvi, M., Al-Sulivany, B., Naeem, M., Selamoglu, Z., Issa alhussein, H. (2025). 'Myricetin: Unleashing Nature’s Anticancer Warrior for A Healthier Tomorrow', Journal of Advanced Pharmacy Research, 9(1), pp. 1-10. doi: 10.21608/aprh.2025.308641.1285
Naqvi, M., Al-Sulivany, B., Naeem, M., Selamoglu, Z., Issa alhussein, H. Myricetin: Unleashing Nature’s Anticancer Warrior for A Healthier Tomorrow. Journal of Advanced Pharmacy Research, 2025; 9(1): 1-10. doi: 10.21608/aprh.2025.308641.1285

Myricetin: Unleashing Nature’s Anticancer Warrior for A Healthier Tomorrow

Article 1, Volume 9, Issue 1, January 2025, Page 1-10  XML PDF (337.66 K)
Document Type: Research Article
DOI: 10.21608/aprh.2025.308641.1285
View on SCiNiTO View on SCiNiTO
Authors
Muhammad Naqvi1; Basim Al-Sulivany email 2; Muhammad Naeem3; Zeliha Selamoglu4; Hamdia Yousif Issa alhussein2
1Medical Director (Hematologist/Oncologist) and Cancer Liason Physician Intermountain Health Care, Denver USA
2Department of Biology, College of Science, University of Zakho, Zakho, Duhok, Iraq
3Department of Agronomy, Animals, Food, Natural Resources and the Environment (DAFNAE), University of Padova, Italy
4Department of Plant Production and Technologies, Faculty of Agricultural Sciences and Technologies, Nigde Omer Halisdemir University, Nigde, Türkiye.
Abstract
Good nutrition is essential for a balanced lifestyle and effectively addresses nutritional disturbances. Nutraceuticals, particularly flavonoids found in plant-derived foods, show diverse medical advantages, particularly anti-inflammatory and antimicrobial, and anti-cancer properties. Myricetin, a flavonol found in fruits and vegetables, is notable due the prospect of nutraceutical benefit and cancer-protective properties. Cancer is a major worldwide health problem, and existing treatments can lead to difficulties. Although breakthroughs in cancer therapy, it's still an important factor of mortality worldwide, with high expenditures and unpleasant consequences. Antioxidant-rich medicinal plants and biologically active compounds have the potential to avoid and treat diseases. To overcome these challenges, the search for alternative anticancer drugs is crucial. Herbal medicines, particularly flavonoids, significantly influence cellular and molecular mechanisms and channels associated with Cancer initiation and metastasis. Myricetin, a dietary flavanol, exhibits notable pharmacological activities, especially in the realm of anticancer effects against various human cancers. Myricetin, a polyhydroxy flavonol, emerges as a promising candidate, in cancer prevention is evident through various mechanisms, making it a subject of extensive research. This review provides a most recent record of research findings on myricetin's anticancer potential, emphasizing its multifaceted contributions, safety considerations, optimal doses for various types of cancer, and implications in experimental studies. Additionally, difficulties such as bioavailability improvement through nano-formulations and the synthesis of derivatives for further exploration are discussed. The evidence gathered underscores myricetin's potential as a synergistic agent with existing anticancer drugs and offers valuable insights for researchers in the field.
Keywords
Myricetin; flavonoids; anticancer; nutraceuticals
Main Subjects
Section A: Natural Products & Metabolomics
Statistics
Article View: 283
PDF Download: 159
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.